These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

317 related items for PubMed ID: 15769393

  • 1. [Improvement of left ventricular hypertrophy by anemic-correcting erythropoietin therapy in chronic renal insufficiency].
    Jiang JP, Hou FF, Gao LZ, Pan YB, Yang NS, Chen W, Shu GY, Chen YM, Chen J, Peng WH, Wu JP, Yang ZM.
    Zhonghua Nei Ke Za Zhi; 2005 Jan; 44(1):25-9. PubMed ID: 15769393
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [Erythropoietin-beta in the treatment of anemia in patients with chronic renal insufficiency].
    Dimković N.
    Med Pregl; 2001 Jan; 54(5-6):235-40. PubMed ID: 11759218
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Target level for hemoglobin correction in patients with diabetes and CKD: primary results of the Anemia Correction in Diabetes (ACORD) Study.
    Ritz E, Laville M, Bilous RW, O'Donoghue D, Scherhag A, Burger U, de Alvaro F, Anemia Correction in Diabetes Study Investigators.
    Am J Kidney Dis; 2007 Feb; 49(2):194-207. PubMed ID: 17261422
    [Abstract] [Full Text] [Related]

  • 9. Renormalization of high cardiac output and of left ventricular size following long-term recombinant human erythropoietin treatment of anemic dialyzed uremic patients.
    Cannella G, La Canna G, Sandrini M, Gaggiotti M, Nordio G, Movilli E, Maiorca R.
    Clin Nephrol; 1990 Dec; 34(6):272-8. PubMed ID: 2073771
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Cardiac mortality prevention in uremic patients. Therapeutic strategies with particular attention to complete correction of renal anemia.
    Berweck S, Hennig L, Sternberg C, Dingerkus H, Ludat K, Hampl H.
    Clin Nephrol; 2000 Feb; 53(1 Suppl):S80-5. PubMed ID: 10746811
    [Abstract] [Full Text] [Related]

  • 12. The long-term behavior and predictors of left ventricular hypertrophy in hemodialysis patients.
    Kutlay S, Dincer I, Sengül S, Nergizoglu G, Duman N, Ertürk S.
    Am J Kidney Dis; 2006 Mar; 47(3):485-92. PubMed ID: 16490628
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Erythropoietin improves anemia exercise tolerance and renal function and reduces B-type natriuretic peptide and hospitalization in patients with heart failure and anemia.
    Palazzuoli A, Silverberg D, Iovine F, Capobianco S, Giannotti G, Calabrò A, Campagna SM, Nuti R.
    Am Heart J; 2006 Dec; 152(6):1096.e9-15. PubMed ID: 17161060
    [Abstract] [Full Text] [Related]

  • 18. Correlation of anemia, secondary hyperparathyroidism with left ventricular hypertrophy in Chronic Kidney Disease patients.
    Datta S, Abraham G, Mathew M, Somasundaram H, Muralidharan TR, Moorthy A, Sathyasekaran, Leslie N.
    J Assoc Physicians India; 2006 Sep; 54():699-703. PubMed ID: 17212016
    [Abstract] [Full Text] [Related]

  • 19. Canadian randomized trial of hemoglobin maintenance to prevent or delay left ventricular mass growth in patients with CKD.
    Levin A, Djurdjev O, Thompson C, Barrett B, Ethier J, Carlisle E, Barre P, Magner P, Muirhead N, Tobe S, Tam P, Wadgymar JA, Kappel J, Holland D, Pichette V, Shoker A, Soltys G, Verrelli M, Singer J.
    Am J Kidney Dis; 2005 Nov; 46(5):799-811. PubMed ID: 16253719
    [Abstract] [Full Text] [Related]

  • 20. Cardiovascular effect of normalizing the hematocrit level during erythropoietin therapy in predialysis patients with chronic renal failure.
    Hayashi T, Suzuki A, Shoji T, Togawa M, Okada N, Tsubakihara Y, Imai E, Hori M.
    Am J Kidney Dis; 2000 Feb; 35(2):250-6. PubMed ID: 10676724
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.